{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:16:37Z","timestamp":1769159797141,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"FAPERJ - Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro"},{"name":"CNPq - Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico"},{"name":"POM\/FIOCRUZ \u2013 Oswaldo Cruz Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13104-016-2360-4","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T13:16:23Z","timestamp":1485177383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Close contact interferon-gamma response to the new PstS1(285\u2013374):CPF10: a preliminary 1-year follow-up study"],"prefix":"10.1186","volume":"10","author":[{"given":"Leonardo Silva","family":"de Araujo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidai","family":"de B\u00e1rbara Moreira da Silva Lins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janaina Aparecida Medeiros","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Carvalho Queiroz","family":"Mello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Helena F\u00e9res","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,23]]},"reference":[{"key":"2360_CR1","unstructured":"Implementing the WHO Stop TB Strategy: a handbook for national tuberculosis control programmes. Geneva: World Health Organization; 2008."},{"issue":"4","key":"2360_CR2","doi-asserted-by":"crossref","first-page":"e59546","DOI":"10.1371\/journal.pone.0059546","volume":"8","author":"RE Steffen","year":"2013","unstructured":"Steffen RE, Caetano R, Pinto M, Chaves D, Ferrari R, Bastos M, de Abreu ST, Menzies D, Trajman A. Cost-effectiveness of quantiferon\u00ae-TB gold-in-tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil. PLoS ONE. 2013;8(4):e59546.","journal-title":"PLoS ONE"},{"issue":"4","key":"2360_CR3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1086\/318706","volume":"32","author":"WM El-Sadr","year":"2001","unstructured":"El-Sadr WM, Perlman DC, Denning E, Matts JP, Cohn DL. A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes. Clin Infect Dis. 2001;32(4):623\u201332.","journal-title":"Clin Infect Dis"},{"key":"2360_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1155\/2011\/814943","volume":"2011","author":"S Ahmad","year":"2011","unstructured":"Ahmad S. Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection. Clin Dev Immunol. 2011;2011:17.","journal-title":"Clin Dev Immunol"},{"key":"2360_CR5","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1164\/ajrccm.161.4.16141","volume":"161","author":"Society AT","year":"2000","unstructured":"Society AT. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med. 2000;161:1376\u201395.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"2360_CR6","first-page":"847","volume":"3","author":"GW Comstock","year":"1999","unstructured":"Comstock GW. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis. 1999;3(10):847\u201350.","journal-title":"Int J Tuberc Lung Dis."},{"key":"2360_CR7","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.transproceed.2013.08.059","volume":"45","author":"JS Kim","year":"2013","unstructured":"Kim JS, Cho JH, Park GY, Kang YJ, Kwon O, Choi JY, Park SH, Kim YL, Kim HK, Huh S, Kim CD. Comparison of QuantiFERON-TB gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation. Transpl Proc. 2013;45:2899\u2013902.","journal-title":"Transpl Proc"},{"key":"2360_CR8","first-page":"1192","volume":"10","author":"MGC Farhat","year":"2006","unstructured":"Farhat MGC, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10:1192\u2013204.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2360_CR9","first-page":"52","volume":"2011","author":"VPS Herrera","year":"1031","unstructured":"Herrera VPS, Parsonnet J, Banaei N. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis. 1031;2011:52.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2360_CR10","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1164\/rccm.200608-1099OC","volume":"175","author":"SM Arend","year":"2007","unstructured":"Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, Cobelens FG, van Houte AJ, Bossink AW. Comparison of two interferon-\u03b3 assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med. 2007;175(6):618\u201327.","journal-title":"Am J Respir Crit Care Med"},{"key":"2360_CR11","first-page":"1","volume":"59","author":"GH Mazurek","year":"2010","unstructured":"Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, Committee IE. Centers for disease C, prevention: updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010. MMWR Recomm Rep. 2010;59:1\u201325.","journal-title":"MMWR Recomm Rep"},{"key":"2360_CR12","first-page":"281","volume":"20","author":"J Killewo","year":"2002","unstructured":"Killewo J. Poverty, TB, and HIV infection: a vicious cycle. J Health Popul Nutr. 2002;20:281\u20134.","journal-title":"J Health Popul Nutr"},{"key":"2360_CR13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1128\/CVI.00726-13","volume":"21","author":"LS Araujo","year":"2014","unstructured":"Araujo LS, Mello FCQ, da Silva NBM, Leung JAM, Machado SMA, Sardella IG, Maciel RM, Saad MH. Evaluation of gamma interferon immune response elicited by the newly constructed PstS-1(285\u2013374): CFP10 fusion protein to detect Mycobacterium tuberculosis infection. Clin Vaccin Immunol. 2014;21:552\u201360.","journal-title":"Clin Vaccin Immunol"},{"key":"2360_CR14","unstructured":"Sa\u00fade BMdSFNd. Manual de recomenda\u00e7\u00f5es para o controle da Tuberculose no Brasil. 2011."},{"key":"2360_CR15","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/nrmicro2459","volume":"8","author":"RW Peeling","year":"2010","unstructured":"Peeling RW, Smith PG, Bossuyt PM. A guide for diagnostic evaluations. Nat Rev Microbiol. 2010;8:S2\u20136.","journal-title":"Nat Rev Microbiol."},{"key":"2360_CR16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1348-0421.2007.tb03910.x","volume":"51","author":"RC Tavares","year":"2007","unstructured":"Tavares RC, Salgado J, Moreira VB, Ferreira MA, Mello FC, Leung JW, Fonseca Lde S, Spallek R, Singh M. MH. S: Interferon gamma response to combinations 38\u00a0kDa\/CFP-10, 38\u00a0kDa\/MPT-64, ESAT-6\/MPT-64 and ESAT-6\/CFP-10, each related to a single recombinant protein of Mycobacterium tuberculosis in individuals from tuberculosis endemic areas. Microbiol Immunol. 2007;51:289\u201396.","journal-title":"Microbiol Immunol"},{"issue":"10","key":"2360_CR17","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1002\/eji.1830221024","volume":"22","author":"HM Vordermeier","year":"1992","unstructured":"Vordermeier HM, Harris DP, Friscia G, Rom\u00e1n E, Surcel HM, Moreno C, Pasvol G, Ivanyi J. T cell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease. Eur J Immunol. 1992;22(10):2631\u20137.","journal-title":"Eur J Immunol"},{"key":"2360_CR18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1128\/IAI.54.1.177-183.1986","volume":"54","author":"D Young","year":"1986","unstructured":"Young D, Rees A, Lamb J, Ivanyi J. Immunological activity of a 38-kilodalton protein purified from Mycobacterium tuberculosis. Infect Immun. 1986;54:177\u201383.","journal-title":"Infect Immun"},{"key":"2360_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pep.2013.11.011","volume":"95","author":"WH Hwang","year":"2014","unstructured":"Hwang WH, Lee WK, Ryoo SW, Yoo KY, Tae GS. Expression, purification and improved antigenicity of the Mycobacterium tuberculosis PstS1 antigen for serodiagnosis. Protein Expr Purif. 2014;95:77\u201383.","journal-title":"Protein Expr Purif"},{"key":"2360_CR20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.tube.2013.07.005","volume":"93","author":"S Khurshid","year":"2013","unstructured":"Khurshid S, Khalid R, Afzal M, Waheed Akhtar M. Truncation of PstS1 antigen of Mycobacterium tuberculosis improves diagnostic efficiency. Tuberculosis (Edinb). 2013;93:654\u20139.","journal-title":"Tuberculosis (Edinb)"},{"key":"2360_CR21","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/eji.201243245","volume":"43","author":"C Palma","year":"2013","unstructured":"Palma C, Schiavoni G, Abalsamo L, Mattei F, Piccaro G, Sanchez M, Fernandez C, Singh M, Gabriele L. Mycobacterium tuberculosis PstS1 amplifies IFN-gamma and induces IL-17\/IL-22 responses by unrelated memory CD4\u00a0+\u00a0T cells via dendritic cell activation. Eur J Immunol. 2013;43:2386\u201397.","journal-title":"Eur J Immunol"},{"key":"2360_CR22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00365540701596011","volume":"40","author":"XYLY He","year":"2008","unstructured":"He XYLY, Zhang XG, Liu YD, Wang ZY, Luo FZ, Zhang JP, Wang Q, Yan SM, Wang YJ, Ma LF, Guo J, Dong YJ, Huang XY, Zhuang YH. Clinical evaluation of the recombinant 38\u00a0kDa protein of Mycobacterium tuberculosis. Scand J Infect Dis. 2008;40:121\u20136.","journal-title":"Scand J Infect Dis"},{"key":"2360_CR23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1183\/09031936.00120214","volume":"45","author":"V Visser de","year":"2015","unstructured":"de Visser V, Sotgiu G, Lange C, Aabye MG, Bakker M, Bartalesi F, Brat K, Chee CB, Dheda K, Dominguez J, et al. False-negative interferon-gamma release assay results in active tuberculosis: a TBNET study. Eur Respir J. 2015;45:279\u201383.","journal-title":"Eur Respir J"},{"key":"2360_CR24","doi-asserted-by":"crossref","first-page":"193923","DOI":"10.1155\/2012\/193923","volume":"2012","author":"J Zu\u00f1iga","year":"2012","unstructured":"Zu\u00f1iga J, Torres-Garc\u00eda T, Santos-Mendoza T, Rodriguez-Reyna TS, Granados G, Yunis EJ. Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Dev Immunol. 2012;2012:193923.","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"2360_CR25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clim.2014.01.010","volume":"151","author":"S Ashenafi","year":"2014","unstructured":"Ashenafi S, Aderaye G, Bekele A, Zewdie M, Aseffa G, Hoang AT, Carow B, Habtamu M, Wijkander M, Rottenberg M, Aseffa A. Progression of clinical tuberculosis is associated with a Th2 immune response signature in combination with elevated levels of SOCS3. Clin Immunol. 2014;151(2):84\u201399.","journal-title":"Clin Immunol."},{"issue":"40","key":"2360_CR26","doi-asserted-by":"crossref","first-page":"33656","DOI":"10.1074\/jbc.M112.375154","volume":"287","author":"VP Dwivedi","year":"2012","unstructured":"Dwivedi VP, Bhattacharya D, Chatterjee S, Prasad DV, Chattopadhyay D, Van Kaer L, Bishai WR, Das G. Mycobacterium tuberculosis directs T helper 2 cell differentiation by inducing interleukin-1\u03b2 production in dendritic cells. J Biol Chem. 2012;287(40):33656\u201363.","journal-title":"J Biol Chem"},{"key":"2360_CR27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2249.2009.03967.x","volume":"157","author":"F Abebe","year":"2009","unstructured":"Abebe F, Bjune G. The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin Exp Immunol. 2009;157:235\u201343.","journal-title":"Clin Exp Immunol"},{"key":"2360_CR28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1471-2334-9-182","volume":"9","author":"OCT Butera","year":"2009","unstructured":"Butera OCT, Carrara S, Casetti R, Vanini V, Meraviglia S, Guggino G, Dieli F, Vecchi M, Lauria FN, Marruchella A, Laurenti P, Singh M, Caccamo N, Girardi E, Goletti D. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response. BMC Infect Dis. 2009;9:182.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2360_CR29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/09031936.00140009","volume":"36","author":"D Goletti","year":"2010","unstructured":"Goletti D, Butera O, Vanini V, Lauria FN, Lange C, Franken KL, Angeletti C, Ottenhoff TH, Girardi E. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur Respir J. 2010;36(1):135\u201342.","journal-title":"Eur Respir J"},{"key":"2360_CR30","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/CVI.00132-07","volume":"14","author":"EMAS Leyten","year":"2007","unstructured":"Leyten EMAS, Prins C, Cobelens FG, Ottenhoff TH, van Dissel JT. Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol. 2007;14:880\u20135.","journal-title":"Clin Vaccine Immunol"},{"key":"2360_CR31","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1128\/CDLI.12.11.1311-1316.2005","volume":"12","author":"DVD Goletti","year":"2006","unstructured":"Goletti DVD, Carrara S, Butera O, Bizzoni F, Bernardini G, Amicosante M, Girardi E. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin Diagn Lab Immunol. 2006;12:1311\u20136.","journal-title":"Clin Diagn Lab Immunol"},{"key":"2360_CR32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CVI.00525-13","volume":"21","author":"K Schepers","year":"2014","unstructured":"Schepers K, Mouchet F, Dirix V, De Schutter I, Jotzo K, Verscheure V, Geurts P, Singh M, Van Vooren JP, Mascart F. Long-incubation-time gamma interferon release assays in response to purified protein derivative, ESAT-6, and\/or CFP-10 for the diagnosis of Mycobacterium tuberculosis infection in children. Clin Vaccine Immunol. 2014;21:111\u20138.","journal-title":"Clin Vaccine Immunol"},{"key":"2360_CR33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/QAI.0000000000000980","volume":"72","author":"V Dirix","year":"2016","unstructured":"Dirix V, Schepers K, Massinga-Loembe M, Worodria W, Colebunders R, Singh M, Locht C, Kestens L, Mascart F. Group T-is: added value of long-term cytokine release assays to detect Mycobacterium tuberculosis infection in HIV-infected subjects in Uganda. J Acquir Immune Defic Syndr. 2016;72:344\u201352.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2360_CR34","doi-asserted-by":"crossref","first-page":"e97366","DOI":"10.1371\/journal.pone.0097366","volume":"9","author":"MK O\u2019Shea","year":"2014","unstructured":"O\u2019Shea MK, Fletcher TE, Beeching NJ, Dedicoat M, Spence D, McShane H, Cunningham AF, Wilson D. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants. PLoS ONE. 2014;9:e97366.","journal-title":"PLoS ONE"},{"key":"2360_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/757152","author":"I Takenami","year":"2012","unstructured":"Takenami I, Finkmoore B, Machado A Jr, Emodi K, Riley LW, Arruda S. Levels of interferon-gamma increase after treatment for latent tuberculosis infection in a high-transmission setting. Pulm Med. 2012;. doi: 10.1155\/2012\/757152 .","journal-title":"Pulm Med"},{"key":"2360_CR36","first-page":"e192","volume":"4","author":"PCBR Hill","year":"2007","unstructured":"Hill PCBR, Fox A, Jackson-Sillah D, Jeffries DJ, Lugos MD, Donkor SA, Adetifa IM, de Jong BC, Aiken AM, Adegbola RA, McAdam KP. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS ONE. 2007;4:e192.","journal-title":"PLoS ONE"},{"key":"2360_CR37","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1371\/journal.pmed.0040208","volume":"4","author":"M Pai","year":"2007","unstructured":"Pai M, O\u2019Brien R. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med. 2007;4:e208.","journal-title":"PLoS Med."},{"key":"2360_CR38","first-page":"603","volume":"83","author":"K Higuchi","year":"2008","unstructured":"Higuchi K, Okada K, Harada N, Mori T. Effects of prophylaxis on QuantiFERON TB-2G responses among children. Kekkaku. 2008;83:603\u20139.","journal-title":"Kekkaku."},{"key":"2360_CR39","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1440-1843.2008.01244.x","volume":"13","author":"K Higuchi","year":"2008","unstructured":"Higuchi K, Harada N, Mori T. Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis. Respirology. 2008;13:468\u201372.","journal-title":"Respirology"},{"issue":"9","key":"2360_CR40","doi-asserted-by":"crossref","first-page":"e85612","DOI":"10.1371\/journal.pone.0085612","volume":"14","author":"A Fujikawa","year":"2014","unstructured":"Fujikawa A, Fujii T, Mimura S, Takahashi R, Sakai M, Suzuki S, Kyoto Y, Uwabe Y, Maeda S, Mori T. Tuberculosis contact investigation using interferon-gamma release assay with chest x-ray and computed tomography. PLoS ONE. 2014;14(9):e85612.","journal-title":"PLoS ONE"},{"key":"2360_CR41","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/381754","volume":"38","author":"S Carrara","year":"2004","unstructured":"Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D. Use of a T cell\u2013based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis. 2004;38:754\u20136.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2360_CR42","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.4049\/jimmunol.167.9.5217","volume":"167","author":"AA Pathan","year":"2001","unstructured":"Pathan AA, Wilkinson KA, Klenerman P, McShane H, Davidson RN, Pasvol G, Hill AV, Lalvani A. Direct ex vivo analysis of antigen-specific IFN-\u03b3-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol. 2001;167(9):5217\u201325.","journal-title":"J Immunol."},{"key":"2360_CR43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/cir321","volume":"53","author":"JD Mancuso","year":"2011","unstructured":"Mancuso JD, Tribble D, Mazurek GH, Li Y, Olsen C, Aronson NE, Geiter L, Goodwin D, Keep LW. Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics. Clin Infect Dis. 2011;53:234\u201344.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-016-2360-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T13:37:49Z","timestamp":1601386669000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-016-2360-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,23]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2360"],"URL":"https:\/\/doi.org\/10.1186\/s13104-016-2360-4","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,23]]},"article-number":"59"}}